- N87.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM N87.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of N87.1 – other international versions of ICD-10 N87.1 may differ.
ICD-10-CM N87.1 is grouped within Diagnostic Related Group(s):
- 742 Uterine and adnexa procedures for non-malignancy with cc/mcc
- 743 Uterine and adnexa procedures for non-malignancy without cc/mcc
- 760 Menstrual and other female reproductive system disorders with cc/mcc
- 761 Menstrual and other female reproductive system disorders without cc/mcc
Applicable To
- Cervical intraepithelial neoplasia II [CIN II]
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to N87.1:
- moderate > cervix (uteri) N87.9
- grade II > cervix (uteri) (CIN) (histologically confirmed) N87.9